Clinical trial · Observational
Long-term Epidemiological Follow-up of Non-small Cell Lung Cancer in Scandinavia
NCT02839629CI-TRIAL-00056728SCAN-LEAFcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A study to describe and evaluate patient characteristics and clinical outcomes in Subjects with diagnosed Non Small Lung Cell Cancer in Sweden, Norway and Denmark.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non-Small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Cohort 1: National patient cohorts in Scandinavia
- description
- Scandinavian countries: Denmark, Norway and Sweden Cohort 1 will include all patients with a diagnosis of NSCLC between 2005 and 2013
- label
- Cohort 2: Electronic Medical Records based cohort (Sweden)
- description
- Patient as data is available (\~2010) to 2013
Primary outcomes (8)
- measure
- Overall survival based on Response Evaluation Criteria in Solid Tumors (RECIST)
- timeFrame
- Approximately 2 years
- description
- Overall survival is defined as the time from start of treatment to the end of follow-up; Clinical outcomes will be assessed among NSCLC patients with advanced (stage IIIB and above) and earlier stage (stages I to IIIA) disease
- measure
- Progression free survival based on Response Evaluation Criteria in Solid Tumors (RECIST)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Patients with a histologically confirmed diagnosis of NSCLC (squamous, adenocarcinoma, not otherwise specified NSCLC \[NSCLC NOS\]) identified in the Cancer registers Exclusion Criteria: * Age under 18 years at time of diagnosis
References
Publications (0)
Data not yet available
No reference posted for this study.